Iberogast

Iberogast, the active ingredient in Iberogast, is a herbal medicine presented as a liquid oral drops for oral use. It is indicated for functional dyspepsia, irritable bowel syndrome and other gastrointestinal discomfort, helping to relieve symptoms such as bloating, nausea and abdominal pain in adult patients, and is used under medical supervision.

GNH USA supplies Iberogast as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies, clinics and research institutions across global markets, with adherence to quality standards and regulatory requirements.

Iberogast is used to manage functional gastrointestinal disorders affecting smooth muscle activity and visceral sensitivity. Functional dyspepsia: reduces upper abdominal discomfort, bloating and early satiety. Irritable bowel syndrome: alleviates abdominal pain, cramping and irregular bowel habits. Gastrointestinal discomfort: eases non‑specific stomach upset, nausea and gas. Functional abdominal pain: lessens recurrent abdominal pain without identifiable organic cause.

Iberogast is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Altered taste sensation: mild metallic or bitter aftertaste. - Mild diarrhea: occasional loose stools. - Nausea: transient feeling of queasiness. - Headache: occasional mild headache.

Serious or Rare Side Effects: - Allergic reactions: rash, itching or swelling. - Hepatotoxicity: elevated liver enzymes or liver injury. - Anaphylaxis: severe, potentially life‑threatening allergic response.

Before using Iberogast, consider the following precautions. Assess patient history: review gastrointestinal disorders and known allergies. Avoid use in severe liver disease: limited safety data are available. Monitor for allergic reactions: discontinue if rash or swelling develops. Use with caution in pregnancy: safety has not been established. Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Iberogast may interact with other medicines; review the following.

Major Interactions (Avoid): - Concomitant use with potent CYP450 inhibitors: may increase exposure to active constituents. - Combination with other antispasmodics: risk of excessive smooth muscle relaxation. - Use with anticoagulants: potential increased bleeding risk due to herbal components.

Moderate Interactions (Monitor Closely): - Concurrent use with pro‑kinetic agents: may augment gastrointestinal motility. - Combination with NSAIDs: monitor for gastrointestinal irritation.